Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

Clinical trial NCT03391934 · UNKNOWN

Trial details

NCT number: NCT03391934
Sponsor: Cinnagen
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2018-01-20
Primary completion: 2025-11-30
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.